chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. Medical history was not reported. The nurse informed that on 02-JUL-2014 the patient was vaccinated with M-M-R II (strength, dosage and route were not reported) lot number: J008728, expiration date: 26-JUL-2015. That may had been improperly stored since February 2014. The thermometer batteyr ran out in February 2014, so the refrigerator temperature was not able to be confirmed to be within recommended storage temperature since then. The highest temeprature the M-M-R II could had been exposed was 70F. Also stated that was no way to detemrine waht the exact temperature was at any given time after 01-FEB-2014 since the batteyr in the thermometer stopped working. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
hot to touch; Injection site size of a golf ball; Arm became very red; Feeling tired; Left arm is sore; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm became very red), MYALGIA (Left arm is sore), FATIGUE (Feeling tired) and VACCINATION SITE SWELLING (Injection site size of a golf ball) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 078C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jul-2021, the patient experienced MYALGIA (Left arm is sore). On 06-Jul-2021, the patient experienced ERYTHEMA (Arm became very red) and FATIGUE (Feeling tired). On 07-Jul-2021, the patient experienced VACCINATION SITE SWELLING (Injection site size of a golf ball). At the time of the report, ERYTHEMA (Arm became very red), FATIGUE (Feeling tired) and VACCINATION SITE SWELLING (Injection site size of a golf ball) outcome was unknown and MYALGIA (Left arm is sore) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Pt was called for 2nd dose following acquisition of stock to finally immunize. Pt refused 2nd dose citing arm pain secondary to first dose of SHINGRIX vaccination which he reports has not since subsided. Arm pain is persistent. Pt reported nothing else beyond that. Pt was advised to visit with their primary care provider and that we would document the adverse even in VAERS.
COVID-19 symptoms started on April 7th or 8th, and a positive COVID-19 test on April 9th. It started with a headache and since I have migraines it's hard to tell but they were more frequent and persistent. I also had back ache, fatigue, and was coughing phlegm, and that's pretty much it. I'm still coughing and have a little fatigue but for the most part I was feeling better by April 13th or 14th. My doctor had me get the Bebtelovimab Infusion injection.
no adverse event; vaccine stored out of recommended storage range was administered to patient; This spontaneous report was received from nurse prescriber referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported.       On 04-MAR-2022, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot # 1687290, expiration date 06-SEP-2022, for prophylaxis (dose, vaccination scheme frequency, route of administration and anatomical site of vaccination were not reported) (product storage error). No additional adverse event reported.
Woke up next day very fatigued, left work after 1/2 day and slept 20hrs  Two days after injection lymph nodes very sore and swollen in armpit (pain with applying deodorant)  Four days after injection bruising with about 3x3 cm area of redness/swelling present at injection site Daily headaches managed with ibuprofen   Not anything too concerning but not comfortable. I have never reacted to a vaccine prior
Reesident received 3rd dose of Pfizer covid vaccine series on the same day, a few hours after the 2nd dose was given.
Red marks and severe itching mostly on the palms of my hands. Fades at times. Wakes me up in the middle of night and Im scratching
Got the Vaccine on Sunday. On Monday had chills, fever, muscle aches. Tuesday started to feel vaginal pain and swelling of vulva. On Wednesday had more chills, episode of fingernails turning blue. Extreme vaginal pain. Thursday went to Gynecologist- diagnosed with ulcers. Sent pictures to dermatologist and diagnosis of Lipschutz ulcers was made. On Friday went to rheumatologist and ruled out any auto-immune disease. Monday- 6/21/21 seen by Dermatologist who confirmed the diagosis of Lipschutz ulcers, believes it came from the covid vaccine. No current treatment available, only supportive care available.
p/receiving TD pt fell to floor w/short period of unconsciousness; VS were stable upon sitting, BP 80/40, pt became diaphoretic & lost consciousness; IV started Epi given; pt put in trendelenberg VSS; transported to ER;vasovagal rxn dx ER
I have been experiencing cluster migraines since the injection. I do not have a history of migraines or severe headaches.
Patient was vaccinated at a retail pharmacy on 11/1 with Moderna vaccine. Shortly after receiving the vaccine patient experienced redness, warmth, pain, and itching at the injection site. Patient contacted his VA primary care team for advise. Nurse and MD advised ice, Tylenol PRN and or Ibuprofen intervention. Because vaccine was not administered at this facility we have limited access to specific vaccine details like lot, expiration, and NDC.
MOM STATES CHILD DEVELOPED RASH AROUND 1200 NOON 11-16-17 ON CHEST, BACK, ARMS, AND LEGS. RECEIVED IMMUNIZATIONS 11-15-17 AROUND 1 PM. MOM STATED ON 11-16-17 THAT CHILD HAD ALSO FELT WARM TO HER BUT SHE COULD NOT FIND THERMOMETER. STATES SHE GAVE INFANT TYLENOL. INFANT ALSO HAD TEMPERTAURE OF 101.9 PER MOM THIS AM, 11-17-17 AND WAS FUSSY. MOM STATES TODAY THAT SHE TOOK INFANT TO EMERGENCY ROOM 11-17-17 AND THAT EMERGENCY ROOM PHYSICIAN SEEMED TO THINK THAT INFANT POSSIBLY HAD AN ALLERGIC REACTION TO VACCINATIONS AND MOM STATES SHE WAS INSTRUCTED THAT RASH COULD POSSIBLY TAKE UP TO FIVE DAYS TO GO AWAY. MOM STATED THAT RASH WAS WORSE THIS AM. MOM ALSO STATES THAT EMERGENCY ROOM DOCTOR TOLD HER TO USE TYLENOL AND IBUPROFEN FOR INFANT.
I had a seizure the morning of 6/29/2021.  Transported to the ER via ambulance and released later that day.
Onset of fever and malaise 24 hours after injection following in two weeks by onset of distal pain and weakness. Admitted to hospital on 3/17/2021 for SoluMedrol 1 gm daily times 4 followed by SoliMedrol dose pack. Developed transient left vision loss and was admitted to Hospital on 4/22/2021 where a diagnosis of eosinophilic granulomatosis with polyangiitis was confirmed by biopsy.  She was started on prednisone 50 mg daily with outpatient rheumatology and physical therapy follow-up.  At two years after onset she is walking with AFOs bilaterally and has some use of her hands (able to grasp a cup).
This spontaneous report as received from a pharmacist refers to a 20-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, concomitant medication, drug reactions and allergies was provided. On 27-JAN-2012, the 13-year-old patient was vaccinated with the first dose of GARDASIL or GARDASIL 9 injection (dose, route of administration, lot number and expiration date were not provided) for prophylaxis. On 31-JAN-2019, the patient was vaccinated with the second dose of GARDASIL 9 injection, lot number M030380, expiration date 01-FEB-2019 (dose and route of administration were not provided) for prophylaxis. No adverse effects were reported.
Violently vomiting; Bad Diarrhea; Chills; fog brain; felt like she was dreaming, she was not herself; Sneezing; Watery eyes; Loss of Appetite; stomach issue; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EP6955), via an unspecified route of administration in left arm on 20Mar2021 14:00 (at the age of 60-years-old) as dose 1, single for COVID-19 immunization. Medical history included diabetes from Jan2001 and ongoing and Borderline cholesterol. Concomitant medications included atorvastatin tablet taken orally for Borderline cholesterol as 40 mg, 1x/day and ongoing and metformin hydrochloride, sitagliptin phosphate monohydrate (JANUMET) taken orally for diabetes as 500-1000 mg, 2x/day. The patient experienced violently vomiting, bad diarrhea, chills, fog brain; felt like she was dreaming, she was not herself, sneezing, watery eyes, loss of appetite and stomach issue on 20Mar2021 18:00. Patient stated that she has done vaccine on Saturday and she wasn't working on the day of this report, so she wanted to talk about her side effect, she was in bad way but overcame it because she read about side effect. Patient stated that on Monday when she woke up, she felt so much better like far better, it was amazing. She just wanted to report that she doesn't know if that was one of the side effects, but she knows people that have had Covid, she does not had Covid reported some stomach issue, she doesn't know if that one of them was from vaccine. Patient stated that she was fine. She will be going for second shot. It was only two and day half. Patient does lot of reading, so she did read just she did know stomach. They did not mention about any stomach issue with the side effects, she was fine. Patient was good, she feels so much better than she did before vaccine. Due date for second dose was 10Apr2021. Patient knew that vaccine have to go through her system. She just slept a lot. Stated that she just let her immune system to work so, she just slept. She did not take anything. She did not take Tylenol. Outcome of events was resolved on 22Mar2021.
On Wednesday an hour and 1/2 after having the first dose of Moderna Covid-19 vaccine, I started having sharp , intermittent chest pains. By Friday the pain had become almost constant and I developed a pretty severe rash on my face and chest. I went to my Mom?s house and she took me to the ER.  I was severely tachycardic and determined to be having an allergic reaction to the Moderna Covid-19 vaccine with cardiac involvement and was admitted to the hospital. I was transported by ambulance from a walk-in ER because the Dr. did not want me to be taken off cardiac monitoring. I was given a very strong antihistamine on day 2 which helped with the rash. I continued to have chest pain for about 6 weeks after this incident and had to avoid caffeine intake as it triggered events.
pt recvd vax; fine macular rash all over body, hands,face, feet,trunk,arms,legs;blanches w/ pressure; rash appeared 12 hrs p/ vax;
Patient reported severe arm pain at the site of injection followed by redness, swelling, warmth and a knot in the arm. Upon the suggestion of the physician she called the pharmacy to report the event.
This spontaneous report as received from a healthcare professional, concerning a 55 year old male patient. Medical history and concurrent conditions were not reported. On 02-JUN-2014, the patient was vaccinated with a dose RECOMBIVAX HB, 1 ml, intramuscular, lot number H017800, expiration date 01-JUN-2014, for vaccination. Co-suspect and concomitant therapies were not reported. On 02-JUN-2014 healthcare professional stated a colleague vaccinated an adult client with expired RECOMBIVAX HB today. No adverse effects reported at this time. Additional information has been requested.
Post-Shingles Vaccine reaction  The symptoms began 2 months ago. The symptoms are reported as being severe. She states the symptoms are chronic. Patient remembers that after she had her second shingles vaccine on her right deltoid, she experienced muscular pain on the site of the injection which radiated across her chest wall then to her other shoulder radiating to her back.  She started to take Tylenol but that was not helpful.  She did try Aleve and she felt  better. Benefit:  Pt has had vasculitic rashes on her shins for years.  She said that after the shingles vaccine, she observed that these rashes went away since.
2 days after vaccination patient presented with erthymetous, indurated patch upper arm 5x6 cm itchy, h/o fever 101.7 overnight. Treated for cellulitis with keflex. Patient had a concurrent otitis media. Patient had a previous reaction, mom cant remember details though thinks she was about 4 years old.
Aggressive swelling on arm of injection from her shoulder to her elbow. Patient also reported chills and wheezing in the following days of receiving vaccine.
Fine red, itching rash began on 10/17/02 11:30pm on arms and feet. Gradually progressed over most of body. No urticaria. Went to ER on 10/19/02 3am. Given Rx: Atarax and Prednisone. Red rash progressed to bruising in groin area.
it was rpt by RN pt recv varivax & approx 1yr later devel 3-4 skin lesions.
At about 10 am on 8/10/2019, patient reported to have faster heartbeat around 100 per minute on the night of the adminstration of the vaccine. She stated that she could not sleep well on the night. She also reported that the injection site on the left arm and the surrounding area was red, warm and swollen. Suggested patient to contact doctor or seek medical attention in medical facilities.
Chills; Fever; Headache; Body aches; Pain and swelling near my collarbone; Pain and swelling near my collarbone; Supraclavicular lymphadenopathy; This is a spontaneous report from a contactable consumer, the patient. A male patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734), via an unspecified route of administration in the right arm on an unknown date, as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known seasonal allergies. The patient did not receive any other medications in two weeks. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204), via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, within the first 36 hours of the second dose, the patient experienced typical adverse effects of chills, fever, headache and body aches. Around 48 hours, the patient began feeling a pain and swelling near the collarbone which the patient soon realized was a supraclavicular lymphadenopathy. This occurred on the same side of the injection in the right arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, fever, headache, body aches, pain and swelling near collarbone and supraclavicular lymphadenopathy were not resolved at the time of reporting.    No follow-up attempts are needed. No further information is expected.
Began to feel itching and swelling in throat at approximately 10 minutes post injection. Stated felt like there was a walnut in her throat. The skin on her neck and face flushed red and she felt dizzy. Developed dry cough and hoarse voice in addition to other symptoms. Was treated with Citirizine 10mg in COVID vaccine clinic. Vital signs were stable during time in clinic. Transferred to ED for treatment. Dr. from anesthesia was ordering provider for medication and treatment.
Ongoing migraines. Dull pain in back of head. Sharp stabbing pains in front of head mainly behind the left eye. Dizziness. First one lasted 15 days straight. Since then they come and go each day.
Raised, red, itchy rash on injection arm. Treated with topical hydrocortisone, oral cetirizine, oral famotidine. Rash resolved by approximately 90%  after ~3-4 hours post-medications.
This case was reported by a healthcare professional and described the occurrence of neck pain in a 52-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). Concurrent medical conditions included asthma, cluster headache, hypotension, hypothyroidism, insomnia, migraine headache, obesity, restless legs syndrome and vitamin d deficiency. Concurrent medications included ARMOUR THYROID, atenolol, SINGULAIR, ADVAIR, BACTROBAN, clotrimazole, fluorometholone, eye medication (eye drop), MAXALT, RESTORIL, ropinirole, "Robinsonade" (Unknown medication), triamcinolone cream, VENTOLIN HFA, ZOFRAN, CLARITIN and ibuprofen. On 30 May 2013 the subject received unspecified dose of BOOSTRIX (.5 ml, unknown route, left arm). On 8 June 2013, 9 days after vaccination with BOOSTRIX, the subject experienced neck pain, neck swelling, shoulder pain, shoulder swelling, pain in trunk, swelling of torso and supraclavicular lymphadenopathy. At the time of reporting the outcome of the events was unspecified.
diagnosed with IBS; A spontaneous report was received from a consumer, who is a female patient of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and was diagnosed with irritable bowel syndrome (IBS).  The patient's medication history was not reported. No relevant concomitant medications were reported.  On an unspecified date, the patient received the second of two planned doses of mRNA-1273 (Lot number: unknown) intramuscularly in left arm for prophylaxis of COVID-19 infection. On an unspecified date after receiving vaccine, the patient experienced body aches, fever and chills. She went into the emergency room and was diagnosed with irritable bowel syndrome. She was self-medicating with acetaminophen for alleviating her symptoms.  The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.  The outcome of the event was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
The pt developed erythematous macular rash on left lower extremity below knee and ankle.
Pain, numbness and tingling throughout arms and legs. Muscle weakness in both arms and legs.
RASH IN LINEAR PATTERN ON RIGHT SIDE, NO PAIN, UNILATERAL IN 1 DERMATOME.
Pt reported Headaches since monday every morning then goes away later in the day.  Pt took Asparin for couple days. As of today Thursday 10/10/19 12:54. Pt does not have headache.
6/12 - patient developed fever and cervical lymphadenopathy. Worsened gradually with difficulty swallowing. 6/16 - presented to ED. Patient also reported rash in right lower extremity that is pruritic, 2 episodes of non-bloody non-bilious emesis daily since Saturday, intermittent chest pain and dyspnea, myalgias, diarrhea, generalized abdominal pain, and neck pain. Concern for infectious mononucleosis with lymphadenitis. Prescribed Augmentin and discharged home. 6/17 - returned to ED due to worsening rash (no longer pruritic) and diarrhea. Continued fever and neck pain. Hypotensive requiring 3L bolus and norepi. Large volume diarrhea. Mild AKI that resolved with fluid resuscitation. Treated broadly with antibiotics for toxic shock syndrome but rash was not consistent and cultures were negative, so eventually narrowed to ampicillin-sulbactam. Neck pain and swelling improved, but fever persisted through 6/19. Transferred to the floor on 6/20 and gradually improved without further intervention. Antibiotics were continued to target possible tonsillitis/lymphadenitis, but course did not seem to be truly responding to these antibiotics. CRP continued to increase despite antibiotics. Patient's presentation seemed most consistent with MIS-C; she also met criteria for incomplete KD with fever, rash, cervical lymphadenopathy and lab abnormalities, but this was felt less likely and she was not treated with IVIG or any other anti-inflammatories. Patient eventually improved and was discharged home 6/24.
patient recieved both vaccines and stood to leave.  about two minutes later patient returned to pharmacy and reported "not feeling well".  Pharmacist guided patient to a chair to sit down.  Once seated, reported feeling dizzy upon being asked what she was experiencing.  Shortly after, patient reported severe back pain, began to become flush, and started to perspire.  Patient was asked if she wanted to emergency services to check her out to which she agreed.  While waiting for their arrival, pharmacist inquired is patient was having any difficultly breathing or if there was any pain originating for injection site which patient denied.  Patient was instructed to take slow, deep breaths to help her remain calm.  After a few minutes, patient reported that pain was subsiding.  Once EMT's had arrived and patient was assessed she was given the option to be transported for further care, which she declined.  After patient had spent a few more minutes seated, she decided to leave.  She was again asked if she was feeling well and was invited to remain if she needed to more time to recover.  Patient declined to remain seated and departed.
This spontaneous report as received from a medical assistant refers to an unknown number of patients of unknown age. On an unknown date the patients might was vaccinated with a dose of VARIVAX (Merck) (lot # not reported) stored as high as 9F for about 2 months. No adverse effect reported. Additional information has been requested.
Patient reports 30 minutes after receiving vaccine arm very sore, very dizzy, and nauseated.
right side axillary lymph node swollen; This is a spontaneous report from a contactable other healthcare professional (HCP). A 27-year-old male patient (a registered nurse) received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Solution for injection; batch/lot number: EK5730, expiration date: unknown), via an unspecified route of administration via injection to the right deltoid on 22Dec2020 at a single dose for COVID-19 immunization as he was working in a high risk patient population in the intensive care unit (ICU). The patient had no medical history. There were no concomitant medications. On 27Dec2020, the patient experienced right side axillary lymph node swollen, which was assessed as non-serious. It was further reported that the patient developed symptoms and stated at the injection site, he had a swollen lymph node, and he called his primary care physician; they did a telehealth visit, and he also reported to the hospital where he received the vaccine and he wanted to fulfill his reporting responsibilities and report to Pfizer, since he had received the vaccine. The patient further clarified the location and stated that the injection site was in the shoulder, but the lymph node was the same side, the axillary lymph node; it was not at the site, it was the axillary lymph node on the right side. The patient had no investigation assessment. The patient was not recovered from the event "right side axillary lymph node swollen." The causal relationship of the drug to the event "right side axillary lymph node swollen" was assessed by the reporting HCP as related; method of assessment: Global Introspection.
This spontaneous report was received from a nurse and refers to two patients of unknown demographics. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX (lot # L029469, expiration date: 06-AUG-2017; dose and route not provided). No adverse effect was reported. Additional information has been requested.
I was PPV vaccinated on 03/01/05 at 3PM. I had a hard sore arm all evening. After going to bed at 12PM I had the shakes for 3 hrs. When I got up in the AM I had sweats and body aches and weak. Missed work.